ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,499Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 1111

$616K Total Retail Price of All Prescriptions

Rank: 141 out of 1111

538 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 538 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

28% of this provider’s 538 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 11,397 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 890 690 S3 1 1
SIMVASTATIN 674 636 2 5
OMEPRAZOLE 627 552 3 4
AMLODIPINE BESYLATE 562 441 4 7
LISINOPRIL 518 471 5 2
LEVOTHYROXINE SODIUM 450 402 6 3
FUROSEMIDE 354 323 7 6
POTASSIUM CHLORIDE 352 333 8 9
METFORMIN HCL 317 287 9 8
LOSARTAN POTASSIUM 267 252 10 34
ZOLPIDEM TARTRATE 261 222 11 16
HYDROCHLOROTHIAZIDE 261 220 11 11
CITALOPRAM HBR 221 181 13 14
PRAVASTATIN SODIUM 213 173 14 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 189 181 15 23
GLYBURIDE 187 175 R 16 59
METOPROLOL TARTRATE 187 173 16 12
GABAPENTIN 156 136 18 10
WARFARIN SODIUM 133 117 19 19
MELOXICAM 133 129 19 18
RANITIDINE HCL 129 101 21 29
DOXAZOSIN MESYLATE 128 128 22 87
NEXIUM 127 79 23 26
DIGOXIN 125 100 24 47
NAPROXEN 119 103 25 85
CARISOPRODOL 119 24 R 25 54
METOPROLOL SUCCINATE 116 96 27 20
ISOSORBIDE MONONITRATE ER 116 106 27 73
GLIPIZIDE 110 96 29 57
CARVEDILOL 108 94 30 21
ALLOPURINOL 107 95 31 36
VERAPAMIL ER 104 91 32 100
LOVASTATIN 103 86 33 41
ATENOLOL 102 89 34 22
TRAZODONE HCL 97 73 35 32
CLOPIDOGREL 96 75 36 30
TIZANIDINE HCL 96 88 36 91
AZITHROMYCIN 88 74 38 39
FINASTERIDE 87 83 39 115
PLAVIX 84 64 40 49
TRAMADOL HCL 82 76 41 13
METHYLPREDNISOLONE 79 68 42 93
TAMSULOSIN HCL 78 66 43 28
IBUPROFEN 78 61 43 66
ADVAIR DISKUS 76 48 45 43
TRIAMTERENE-HCTZ 67 61 46 80
DONEPEZIL HCL 66 66 47 25
ATORVASTATIN CALCIUM 63 46 48 15
FLUTICASONE PROPIONATE 63 51 48 27
LANTUS 62 56 50 46
SERTRALINE HCL 60 43 51 24
CIPROFLOXACIN HCL 57 49 52 58
PREDNISONE 57 42 52 48
PAROXETINE HCL 54 48 54 55
LANTUS SOLOSTAR 51 44 55 135
AMLODIPINE BESYLATE-BENAZEPRIL 51 42 55 67
METHOTREXATE 50 49 57 284
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.